Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gi Hyun Kim
Institution:
Ministry of Food and Drug Safety
Observed institutions:
Ministry of Food and Drug Safety,
Duke University,
The University of Tokyo,
Pharmaceuticals and Medical Devices Agency
OpenAlex ID:
A5113924111
The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019
2020
·
Hye-Na Kang
, Robin Thorpe
, et al.
·
Biologicals
·
63
PDF
Regulatory challenges with biosimilars: an update from 20 countries
2020
·
Hye‐Na Kang
, Robin Thorpe
, et al.
·
Annals of the New York Academy of Sciences
·
52
PDF
Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers
2018
·
H. Kim Lyerly
, Jun Ren
, et al.
·
Journal of Global Oncology
·
10
WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25–26 June 2019
2020
·
Meenu Wadhwa
, Hye-Na Kang
, et al.
·
Biologicals
·
5
Show more works
View as search
Works count:
4
Citation count:
130
H-index:
4
I10-index:
3
Year
Topic
Type
